ARCHIVES

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014